Category Archives: Pr Newswire

Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference

FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences: CFO, Peter Kuipers, will participate in a fireside chat presentation […]

TransCode Therapeutics, Inc. Announces Closing of Public Offering

BOSTON, July 24, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously announced public offering of 10,000,000 shares of its common stock at a public offering price of $0.30 per […]

Allianz Partners Australia Simplifies Travel Insurance Purchase for Singapore Airlines Passengers with Integrated Purchase Model

BRISBANE, Australia, July 25, 2024 /PRNewswire/ – Allianz Partners Australia proudly expands its collaboration with Singapore Airlines (SIA) to offer travel insurance to Australian customers integrated in the Singapore Airlines online purchase path. This advancement builds on the existing retail product allowing for a more seamless purchase process and enhanced overall experience for Singapore Airlines […]

State Grid Zhejiang Electric Power Boosts Local Grape Industry with Custom Power Solutions

NINGBO, China, July 25, 2024 /PRNewswire/ — In picturesque Linshanzhen, a town in Zhejiang Province’s Yuyao District, a vast vineyard landscape stretches over 800 hectares (1,975 acres), marking a significant milestone in the region’s agricultural development. The Weixiangyuan Grape Farmer Cooperative stands at the forefront of this transformation, having adopted cutting-edge double- and triple-layer greenhouse technologies […]

Biometrics for Dogs and Cats: Petnow App Launches in Australia and New Zealand

SEOUL, South Korea, July 25, 2024 /PRNewswire/ — Petnow Inc. announced the launch of its award-winning Petnow app in Australia and New Zealand. This innovative, AI-driven application uses advanced pet biometrics to help reunite lost dogs and cats with their owners by scanning and identifying the noses of dogs and the faces of cats through […]

Jackery Introduces Explorer 1000 Plus and 600 Plus Portable Power Stations to the Australian Market

Elevating Portable Power Solutions with Superior Capacity, Versatility, and Eco-Friendly Innovation SYDNEY, July 25, 2024 /PRNewswire/ — Jackery, a global leader in innovative portable power solutions, is excited to announce the launch of its latest products, the Explorer 1000 Plus and Explorer 600 Plus, in the Australian market. These new models are set to redefine […]

Sygnum Posts Profit and Sets Stage for MiCA-compliant expanded EU Market Entry

H1 2024 profit driven by strong business performance, including 500% rise in crypto derivatives trading, >360% increase in loan volumes[i] and >1,000 daily trades with 20+ B2B partner banks servicing more than a third of Swiss population Sygnum now holds ~$4.5 billion in client assets as well as >$125m USD equivalentcore equity capital, following January $40m capital […]

R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives

Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) — The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, […]

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate […]

ImPact Biotech Receives a €13.5M Investment Commitment from the European Innovation Council’s Accelerator Program

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) — ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors, today announced investment commitment of €13.5M from the European Innovation Council’s (EIC) Accelerator program, including a grant of €2.5M and a conditional equity investment […]